Rui Wu

3.3k total citations · 2 hit papers
71 papers, 1.9k citations indexed

About

Rui Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Rui Wu has authored 71 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 17 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Rui Wu's work include RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). Rui Wu is often cited by papers focused on RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). Rui Wu collaborates with scholars based in China, United States and South Korea. Rui Wu's co-authors include Yanjing Zhu, Lei Chen, Hongyang Wang, Wenqi Li, Shuai Yang, Tong Wu, Yirong Wang, Yifeng Zhou, Binbin Guo and Shenghua Zhang and has published in prestigious journals such as The Journal of Experimental Medicine, The EMBO Journal and Hepatology.

In The Last Decade

Rui Wu

66 papers receiving 1.9k citations

Hit Papers

M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tum... 2021 2026 2022 2024 2021 2021 50 100 150

Peers

Rui Wu
Andrea S. Richardson United States
Thomas Frank United States
Jason M. Sheltzer United States
Lana McClements Australia
Kathleen Kuehn New Zealand
James A. Marcum United States
Kun Zhao China
Rui Wu
Citations per year, relative to Rui Wu Rui Wu (= 1×) peers Guoliang Huang

Countries citing papers authored by Rui Wu

Since Specialization
Citations

This map shows the geographic impact of Rui Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Wu more than expected).

Fields of papers citing papers by Rui Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Wu. The network helps show where Rui Wu may publish in the future.

Co-authorship network of co-authors of Rui Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Wu. A scholar is included among the top collaborators of Rui Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Wu. Rui Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qi, Zheng Li, Rui Wu, et al.. (2025). A hyperbranched polysiloxane with imine bonds: red fluorescence emission with a long fluorescence lifetime at room temperature. Journal of Materials Chemistry B. 13(37). 11687–11695.
2.
Zhao, Saili, Rui Wu, Xiaoxuan Tang, et al.. (2024). KBTBD8/RRP15 as a potential novel therapeutic target associates with lenvatinib-inhibited progression in hepatocellular carcinoma both in vitro and in vivo. Journal of Advanced Research. 76. 569–583. 1 indexed citations
3.
Zhang, Yu, Rui Wu, Guodong Ma, et al.. (2024). Evaluation of Inflammatory Markers in Patients with COVID-19 Combined with Type 2 Diabetes Mellitus. Risk Management and Healthcare Policy. Volume 17. 2535–2545. 2 indexed citations
4.
Wu, Rui, et al.. (2024). Silencing circLDLRAD3 Inhibits Lung Cancer Progression by Regulating the miR-497-5p/PFKP Axis. Molecular Biotechnology. 67(1). 260–271. 1 indexed citations
5.
Xue, Xinyan, Jing Wang, Ke Fu, et al.. (2023). The role of miR-155 on liver diseases by modulating immunity, inflammation and tumorigenesis. International Immunopharmacology. 116. 109775–109775. 12 indexed citations
6.
Zhao, Jiajia, et al.. (2023). Ethanol extract of Piper wallichii ameliorates DSS-induced ulcerative colitis in mice: Involvement of TLR4/NF-κB/COX-2 signaling pathway. Journal of Ethnopharmacology. 308. 116293–116293. 9 indexed citations
7.
Wang, Cheng, Rui Wu, Lihong Gong, et al.. (2023). A comprehensive review on pharmacological, toxicity, and pharmacokinetic properties of phillygenin: Current landscape and future perspectives. Biomedicine & Pharmacotherapy. 166. 115410–115410. 21 indexed citations
9.
Li, Zhixuan, Ren-qi Yao, Qingbao Cheng, et al.. (2022). Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment. npj Precision Oncology. 6(1). 58–58. 8 indexed citations
10.
Zhao, Jiajia, et al.. (2022). A review of the genus Chrysosplenium as a traditional Tibetan medicine and its preparations. Journal of Ethnopharmacology. 290. 115042–115042. 4 indexed citations
11.
Qiu, Xinyao, Shuai Yang, Shan Wang, et al.. (2021). M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma. Cancer Research. 81(18). 4778–4793. 174 indexed citations breakdown →
12.
Wu, Rui, et al.. (2021). Regulatory effect of m6A modification on different viruses. Journal of Medical Virology. 93(11). 6100–6115. 9 indexed citations
13.
Zhang, Pingan, Qian Sun, Yongchang Li, et al.. (2020). Overexpression of Purinergic P2X4 Receptors in Hippocampus Rescues Memory Impairment in Rats with Type 2 Diabetes. Neuroscience Bulletin. 36(7). 719–732. 14 indexed citations
14.
Wang, Yirong, Siqi Wu, Xun Zhu, et al.. (2019). LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis. The Journal of Experimental Medicine. 217(3). 177 indexed citations
15.
Zhu, Yanjing, Bo Zheng, Guijuan Luo, et al.. (2019). Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma. Theranostics. 9(12). 3526–3540. 202 indexed citations
16.
Guo, Binbin, Siqi Wu, Xun Zhu, et al.. (2019). Micropeptide CIP 2A‐ BP encoded by LINC 00665 inhibits triple‐negative breast cancer progression. The EMBO Journal. 39(1). e102190–e102190. 194 indexed citations
17.
Tian, Yu, et al.. (2018). Association Between Specific Internet Activities and Life Satisfaction: The Mediating Effects of Loneliness and Depression. Frontiers in Psychology. 9. 1181–1181. 54 indexed citations
18.
Wu, Rui. (2017). Investigation on the current situation of career identity of nurses in large Third-grade class-A hospitals. International journal of nursing. 36(8). 1030–1034. 3 indexed citations
19.
Li, Jianqiao, Rui Wu, Qin Liu, & Hong Wang. (2014). [Relationship of sub-health status to social support and coping styles of left-behind middle school students in a reservoir area of Chongqing].. PubMed. 43(5). 759–63. 1 indexed citations
20.
Wu, Rui, Jianqiao Li, Qin Liu, & Wang Hong. (2014). [Influences of life event and coping style on left-behind middle school student mental health in a three-gorge area county].. PubMed. 43(4). 586–90. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026